Table 2 Previously reported cases and the present case of acute pancreatitis developing after administration of corticosteroid pulse therapy
References (year) | Age (yr) / Sex | Primary Disease | Cardinal symptoms | Doses of steroids | Peak serum amylase (U/L) | Period for treatment at the episode (day) | Concomitant drugs | Outcome |
|---|---|---|---|---|---|---|---|---|
The present case | 51/F | Autoimmune hepatitis | Back pain | mPSL 1000 mg/day, then PSL 60 mg/day | 436 | 5 | Famotidine | Survived |
Nishimoto et al. [20] (2014) | 18/M | Acute monocytic leukemia | Abdominal pain | mPSL 1000 mg/day | 451 | 5 | Cytarabine, imipenem/cilastatin, piperacillin/tazobactam, vancomycin, meropenem | Survived |
Jimi et al. [21] (2013) | 70/F | ANCA-associated nephritis | Epigastric pain | mPSL 1000 mg/day, then PSL 35 mg/day | 2400 | 5 | NA | Survived |
Suganuma et al. [22] (2012) | 2/M | Kawasaki Disease | Abdominal pain | mPSL 15 mg/kg/day (BW, 13.5 kg), then PSL 10 mg/day for 3 days, then 5 mg/day for 3 days | 2075 | 7 | Flurbiprofen | Survived |
Iwata et al. [23] (2010) | 9/F | MPO-ANCA-associated glomerulonephritis | Abdominal pain | mPSL 30 mg/kg/day (BW, 22.8 kg), then PSL 25 mg/day | 159 | 5 | Mizoribine | Survived |
Tsuruoka et al. [24] (2008) | 72/F | ANCA-associated glomerulonephritis | Back pain, epigastric pain | mPSL 500 mg/day, then PSL 20 mg/day | 306 | 20 | NA | Died |
Nakayama et al. [25] (2004) | 60/F | MPO-ANCA-associated glomerulonephritis | Epigastric pain | mPSL 500 mg/day, then PSL 40 mg/day | 1519 | 5 | Cyclophosphamide | Survived |
Kotaka et al. [26] (2002) | 67/F | Myasthenia gravis | Back pain, vomiting | mPSL 1 g/day | 3593 | 2 | NA | Survived |
Yoshizawa et al. [7] (1999) | 80/F | Bullous pemphigoid | Nausea, epigastric pain | mPSL 1 g/day, then PSL 30 mg/day | 1195 | 4 | Alfacalcidol, calcium lactate, propentofylline, vinpocetine, omeprazole | Survived |